15-Minute Saliva Test Aims to Close Tetanus Vaccination Gap
Drug Topics
JULY 12, 2024
Global coverage for diphtheria, tetanus, and pertussis has reached its lowest point in 15 years.
Fri.Jul 12, 2024
500 
BMS’ long-standing leukemia blockbuster stares down its first generic
PharmaVoice
JULY 12, 2024
Patent disputes in the U.S. and abroad have opened the door to new generics ready for launch as soon as September for BMS’ Sprycel.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Stigmatization Plays Key Role in the Mental Health of Children with Skin Disease
Drug Topics
JULY 12, 2024
Researchers aimed to address the extent of stigmatization’s effect on the mental health of adolescents with chronic skin disorders.
Nicotine Replacement Therapy Benefits Tobacco Cessation Efforts
Pharmacy Times
JULY 12, 2024
Helping patients overcome barriers to accessing these treatments is a vital role for pharmacists, who can support patients who are looking to quit.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pfizer Advances Oral GLP-1 Development as the Race for Second-Gen Obesity Therapies Continues
Drug Topics
JULY 12, 2024
Pfizer joins Eli Lilly and Novo Nordisk in the development of oral GLP-1 receptor agonist candidates.
Study Supports Use of Buprenorphine Injections to Treat Minimal to Mild Opioid Use Disorder
Pharmacy Times
JULY 12, 2024
Results show that daily injections of buprenorphine over a 7-day period was safe and well-tolerated in patients who had Clinical Opioid Withdrawal Scale scores of 4 to 7.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Researchers Identify Links Between Gut Microbiome and Autism, Potentially Paving the Way for New Diagnostics
Pharmacy Times
JULY 12, 2024
Unique gut flora were found in children with autism spectrum disorder (ASD).
ONC's HTI-2 proposed rule 'big step forward' for interoperability, health IT experts say, but EHR vendors concerned about timelines
Fierce Healthcare
JULY 12, 2024
ONC's HTI-2 proposed rule 'big step forward' for interoperability, health IT experts say, but EHR vendors concerned about timelines hlandi Fri, 07/12/2024 - 14:43
Opinion: Adaptive trial designs will increase clinical trial speed, safety, and effectiveness
STAT
JULY 12, 2024
Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale for clinical trials. Over the past decade, precision medicine has evolved from merely creating personalized treatment plans and delivery methods to being integral throughout the entire drug development process.
Proposed Medicare codes could lift digital health sector
pharmaphorum
JULY 12, 2024
A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the digital health sector.The Medicare Physician Fee Schedule (PFS) sets out the method of payment, rates, and codes for healthcare providers participating in Medicare, and is often used by the administration as an instrument to encourage some forms of healthcare intervention.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Colorado dropped Medicaid enrollees as red states have, alarming advocates for the poor
Fierce Healthcare
JULY 12, 2024
Colorado stands out among the 10 states that have disenrolled the highest share of Medicaid beneficiaries since the U.S. | Colorado stands out among the 10 states that have disenrolled the highest share of Medicaid beneficiaries since the U.S. government lifted a pandemic-era restriction on removing people from the health insurance program.
Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study
Fierce Pharma
JULY 12, 2024
Trials have already shown that Novo Nordisk’s semaglutide | Trials have already shown that Novo Nordisk’s semaglutide can cut the risk of cardiovascular events and kidney disease. Now a study from the University of Oxford indicates that the company’s semaglutide type 2 diabetes drug Ozempic can reduce the risk of dementia compared with another popular diabetes medicine.
CAR-T therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies
STAT
JULY 12, 2024
Researchers were perplexed when the Food and Drug Administration announced it was investigating whether CAR-T therapy, one of the most effective treatments for blood cancers, could cause lymphoma. This was always a theoretical risk of genetically engineered therapies like CAR-T, but it never materialized in the decades after the technology’s birth.
NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis
Pharmaceutical Technology
JULY 12, 2024
The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Opinion: Unsettling truths about maternal mortality in the U.S.
STAT
JULY 12, 2024
Grave warnings of a crisis in maternal deaths are being slightly eroded by articles suggesting that advocates overreached and that the “crisis” was primarily a function of measurement error. Both sides are partially right, because measuring maternal mortality is uniquely challenging. The question at the heart of identifying a maternal death — “Would this person have died if she hadn’t been pregnant?
DNA sequencer Element Bio raises $277m to take on Illumina
pharmaphorum
JULY 12, 2024
Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round
Industry Voices—Prior authorization regulations: Where they fall short, where we’re moving the needle
Fierce Healthcare
JULY 12, 2024
Initially meant to protect patients from unnecessary procedures, prior authorizations have shifted towards being a cost containment strategy for health payers. | Regulations and policies are moving the industry in the right direction, but there is still room for improvement in key areas where regulations don't go far enough.
Coming soon: New EU Artificial Intelligence Act
pharmaphorum
JULY 12, 2024
Stay informed about the upcoming EU Artificial Intelligence Act, which will regulate AI use in compliance with EU standards. Learn how this legislation may impact your organisation's AI initiatives.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Pharmalittle: We’re reading about a study of Ozempic and dementia, smaller PBMs, and more
STAT
JULY 12, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We hope to catch up on our reading, promenade with the official mascots, and stop by a favorite festival. We may also hold another listening party, where the rotation will likely include this , this , this , this and this.
Do Not Underestimate RSV or Your Importance in Recommending Vaccines
Pharmacy Times
JULY 12, 2024
Pharmacists’ awareness of respiratory syncytial virus and their role in educating about the vaccine have grown dramatically.
Element Biosciences raises another massive round
STAT
JULY 12, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we talk about an Illumina competitor’s newest influx of funding, Adam weighs in on Pfizer’s plan for a once-a-day GLP-1 pill, and more.
Connecting the clinical, regulatory, and commercial dots for rare diseases
pharmaphorum
JULY 12, 2024
Learn how to effectively connect the clinical, regulatory, and commercial aspects in the development of treatments for rare diseases. Discover strategies and insights for navigating the unique challenges of rare disease drug development.
UK needs Covid-style push on dementia drugs, says ex-head of vaccine taskforce
The Guardian - Pharmaceutical Industry
JULY 12, 2024
Kate Bingham says ageing population means tackling dementia must be treated as economic imperative A Covid-style effort is needed to ensure NHS patients are first in line for a new wave of dementia drugs, according to the former head of the UK’s vaccine taskforce. Kate Bingham is calling for the immediate recruitment of large numbers of patients to ensure that, as with Covid vaccines, the UK is a leading player in testing and launching drugs.
Streeting orders “raw and frank” investigation of NHS
pharmaphorum
JULY 12, 2024
New UK Health Secretary Wes Streeting orders a 'raw and frank' review of NHS to inform a new 10-year plan to fix it
Pharma Pulse 7/12/24: The Weight-Loss Gold Rush, GSK Begins Shipping 24-25 Influenza Vaccines & more
Pharmaceutical Commerce
JULY 12, 2024
The latest news for pharma industry insiders.
When to take L-carnitine
The Checkup by Singlecare
JULY 12, 2024
L-carnitine is a common form of carnitine , an amino acid found in animal products, especially red meat. A vegan diet may be low in carnitine content. According to the National Institutes of Health (NIH), it is also naturally produced in the human liver, kidneys, and brain. It is found in the highest concentrations in the brain and skeletal muscle. L-carnitine is vital for mitochondria function and fatty acid oxidation—essentially, it helps with energy production by transforming fat into fuel fo
STAT+: Up and down the ladder: The latest comings and goings
STAT
JULY 12, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pfizer selects once-daily GLP-1 for its obesity push
pharmaphorum
JULY 12, 2024
Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate.The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later this year.
Counsel Patients Who Have Questions About Maternal RSV Immunizations
Pharmacy Times
JULY 12, 2024
RSVpreF is currently the only FDA-approved RSV vaccine for pregnant individuals.
Ipsen gains global rights to Foreseen Biotech’s FS001 ADC
Pharmaceutical Technology
JULY 12, 2024
Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech for FS001, a potentially first-in-class ADC.
Heterogeneity Observed in Reporting on Drug-Drug Interactions With Proton Pump Inhibitors
Pharmacy Times
JULY 12, 2024
An analysis of interaction checkers and product summaries revealed large differences in the consistency and reliability of providing accurate information on potential drug-drug interactions.
Abecma competition, Sotyktu pricing pressure and IRA: Analysts outline Bristol Myers’ top challenges
Fierce Pharma
JULY 12, 2024
Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the future—despite a few promising growth opportunities the team has identified. | Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the drugmaker—despite a few promising growth opportunities they identified.
Novo Nordisk announces $4.1BN investment to expand US manufacturing capacity
Outsourcing Pharma
JULY 12, 2024
On June 24, Novo Nordisk revealed plans for a $4.1 billion investment in a new manufacturing facility in Clayton, North Carolina.
Let's personalize your content